PortfoliosLab logo

BioCryst Pharmaceuticals, Inc. (BCRX)

Equity · Currency in USD · Last updated Sep 20, 2022

Company Info

ISINUS09058V1035
CUSIP09058V103
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$13.58
Year Range$7.89 - $19.76
EMA (50)$13.08
EMA (200)$13.10
Average Volume$2.67M
Market Capitalization$2.45B

BCRXShare Price Chart


Chart placeholderClick Calculate to get results

BCRXPerformance

The chart shows the growth of $10,000 invested in BioCryst Pharmaceuticals, Inc. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $19,971 for a total return of roughly 99.71%. All prices are adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%AprilMayJuneJulyAugustSeptember
-17.24%
-12.49%
BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

BCRXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-3.89%-7.77%
6M-16.28%-12.62%
YTD-1.95%-18.18%
1Y-13.50%-12.03%
5Y20.16%9.26%
10Y12.46%10.35%

BCRXMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202211.55%7.51%-2.11%-42.87%0.22%13.64%4.16%26.13%-2.30%
202114.36%26.53%-5.66%14.45%35.48%0.25%1.96%-1.24%-9.74%3.90%-19.22%14.84%
2020-17.39%5.26%-33.33%95.50%14.96%6.01%-14.59%1.97%-17.23%11.21%33.77%45.79%
20197.56%-4.84%-1.45%-8.72%-52.89%8.29%-16.36%-5.68%-4.18%-30.19%42.50%21.05%
2018-8.35%10.44%-4.02%3.14%30.69%-10.89%2.97%21.36%6.56%-4.06%25.41%-12.09%
2017-0.47%-0.95%34.62%-24.52%-18.77%7.96%-8.09%-0.20%2.75%-14.12%12.89%-3.35%
2016-32.46%-71.45%42.21%15.19%3.99%-16.22%27.46%13.54%7.30%-8.16%38.02%13.24%
2015-16.28%0.20%-11.47%2.88%20.67%33.18%3.68%-24.81%-2.06%-21.14%18.02%-2.73%
201434.21%14.61%-9.50%-18.81%15.95%28.01%-1.80%7.83%-27.56%19.84%-7.76%12.49%
201314.08%-25.93%-0.83%68.91%-14.93%-9.36%183.87%45.00%14.11%-20.95%12.08%17.83%
201241.30%33.52%3.65%-25.05%-14.36%28.06%11.84%-1.58%-2.97%-31.37%-40.89%-17.44%
2011-20.31%5.34%-12.67%2.51%-10.42%9.77%-10.99%-2.94%-16.36%11.23%-6.19%-14.24%
20100.59%-6.43%2.66%15.53%-6.72%-16.53%1.02%-20.77%4.44%0.40%-0.40%4.66%

BCRXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioCryst Pharmaceuticals, Inc. Sharpe ratio is -0.17. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.17
-0.56
BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

BCRXDividend History


BioCryst Pharmaceuticals, Inc. doesn't pay dividends

BCRXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-31.28%
-18.69%
BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

BCRXWorst Drawdowns

The table below shows the maximum drawdowns of the BioCryst Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioCryst Pharmaceuticals, Inc. is 90.33%, recorded on Nov 14, 2019. It took 391 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.33%Jul 15, 20151094Nov 14, 2019391Jun 7, 20211485
-85.65%Apr 30, 2010714Mar 1, 2013213Jan 3, 2014927
-60.07%Feb 17, 202259May 12, 2022
-42.56%Mar 6, 201445May 8, 201437Jul 1, 201482
-41.98%Aug 11, 2014157Mar 25, 201559Jun 18, 2015216
-36.66%Aug 10, 202183Dec 6, 202145Feb 9, 2022128
-25.55%Jan 24, 201410Feb 6, 201412Feb 25, 201422
-23.5%Jan 12, 201020Feb 9, 201041Apr 9, 201061
-17.74%Jul 2, 201411Jul 17, 201412Aug 4, 201423
-14.68%Apr 13, 201011Apr 27, 20102Apr 29, 201013

BCRXVolatility Chart

Current BioCryst Pharmaceuticals, Inc. volatility is 50.46%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%AprilMayJuneJulyAugustSeptember
50.46%
30.26%
BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)